MedTrace Logo

Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance

NCT04721600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-06-11

Study results available
· View outcomes & findings →

Summary

Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance

Conditions

  • Skin Laxity

Interventions

DEVICE

Evoke Radiofrequency Device

Enrolled subjects will undergo up to 3 successive bi-weekly (every 2 weeks) treatments.Treatment area will include face and under chin

Sponsors & Collaborators

  • InMode MD Ltd.

    lead INDUSTRY

Principal Investigators

  • Jeffrey Dover, MD · Skincare physicians

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-07-28
Completion
2022-07-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04721600 on ClinicalTrials.gov